Improving Patient Quality of Life

At Endoprotech we strive to find solutions. Novel ideas that focus on advancing patient care that prevailing science is just beginning to understand. Our strength is in looking for solutions not simply through the lens of transforming human health but also transforming the patients quality of life.

Our Focus

EndoProtech Inc. develops novel liposome-based therapies to treat vascular inflammatory disease.

Our Therapeutic Breakthroughs




EndoGuard: Intra-coronary administration of drug in pre-clinical studies demonstrated a 50% reduction in infarct size. EndoGuard will be utilized as an adjuvant to percutaneous coronary intervention (PCI) to attenuate reperfusion injury in patients with myocardial infarction.


Endohepal: Administration of drug in pre-clinical studies demonstrated a reduction in inflammation and fatty liver in models of alcoholic liver disease.


Going Forward

EndoProtech – Advancing the science of drug-delivery. Through dedication and innovation, we will continue to research effective ways to offer patients the highest quality of life through unique drug-delivery systems.


Contact Us



Submitting Form...

The server encountered an error.

Form received.



1044 E. Chestnut St

Louisville, KY 40204-1019


Phone: 502-742-8555

Toll Free: 1-844-662-2249

Fax: 502-315-3201

©2019 EndoProtech Inc.

All rights reserved.

Website by:

Taylor Advertising LLC

Improving Patient Quality of Life